Rezolute Inc
(NAS:RZLT)
$
4.75
-0.1 (-2.06%)
Market Cap: 252.04 Mil
Enterprise Value: 179.70 Mil
PE Ratio: 0
PB Ratio: 2.68
GF Score: 36/100 Rezolute Inc (RZLT) Transcripts
- Rezolute Inc RZ358 Phase 3 Planning Update Call TranscriptJun 27, 2023
- Rezolute Inc Annual Shareholders Meeting TranscriptMay 25, 2023
- Rezolute Inc RZ402 Phase 2 clinical program - Corporate Call TranscriptMar 22, 2023
- Rezolute Inc at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Rezolute Inc Annual Shareholders Meeting TranscriptJun 16, 2022
- Rezolute Inc Annual Shareholders Meeting TranscriptMay 26, 2021
- Rezolute's Keith Vendola, Ph 2b Initiated, RZ358, Congenital Hyperinsulinism TranscriptFeb 14, 2020
- Rezolute's Keith Vendola Presents at 2020 Biotech Showcase in San Francisco TranscriptJan 14, 2020
- 1